Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
1
pubmed:dateCreated
2004-12-15
pubmed:abstractText
We recently showed that the levels of secreted human leukocyte antigen-G (HLA-G), a nonclassical MHC class I antigen, are significantly elevated in malignant effusions in ovarian carcinoma compared to benign ones. The objective of this study was to evaluate the expression and clinical role of HLA-G in effusions and corresponding solid tumors from patients diagnosed with advanced-stage ovarian carcinoma.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Jan
pubmed:issn
0090-8258
pubmed:author
pubmed:issnType
Print
pubmed:volume
96
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
42-7
pubmed:dateRevised
2011-11-17
pubmed:meshHeading
pubmed-meshheading:15589578-Adult, pubmed-meshheading:15589578-Aged, pubmed-meshheading:15589578-Aged, 80 and over, pubmed-meshheading:15589578-Antibodies, Monoclonal, pubmed-meshheading:15589578-Ascitic Fluid, pubmed-meshheading:15589578-Female, pubmed-meshheading:15589578-HLA Antigens, pubmed-meshheading:15589578-HLA-G Antigens, pubmed-meshheading:15589578-Histocompatibility Antigens Class I, pubmed-meshheading:15589578-Humans, pubmed-meshheading:15589578-Immunohistochemistry, pubmed-meshheading:15589578-Middle Aged, pubmed-meshheading:15589578-Neoplasm Metastasis, pubmed-meshheading:15589578-Neoplasm Staging, pubmed-meshheading:15589578-Ovarian Neoplasms, pubmed-meshheading:15589578-Pleural Effusion, pubmed-meshheading:15589578-Prognosis, pubmed-meshheading:15589578-Tumor Markers, Biological
pubmed:year
2005
pubmed:articleTitle
HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma.
pubmed:affiliation
Department of Pathology, The Norwegian Radium Hospital, University of Oslo, Montebello N-0310 Oslo, Norway. bend@ulrik.uio.no
pubmed:publicationType
Journal Article